Biggest News Aggregation in the World
📰 Cientific News

Page 66 - Cientific News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cientific. Real-time updates on events, politics, business and more.

NervGen Pharma Corp.: NervGen Pharma Presenting Phase 1b/2a Study Design at American Spinal Injury Association 50th Annual Scientific Meeting

Phase 1b/2a trial expected to commence in Q3 2023First readout anticipated in 2024Vancouver, British Columbia--(Newsfile Corp. - April 13, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen"
British Columbia United Kingdom United States Nancy Thompson Shirley Ryan Abilitylab Huitt Tracey

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AB Science: Results of masitinib in ALS selected for a scientific platform presentation at the AAN 2023, including long-term survival analysis and a new analysis of patient population with no complete loss of function at baseline

  PRESS RELEASE RESULTS OF MASITINIB IN ALS SELECTED FOR A SCIENTIFIC PLATFORM PRESENTATION AT THE AMERICAN ACADEMY OF NEUROLOGY 2023 ANNUAL MEETING, INCLUDING LONG-TERM... | April 12, 2023
United States France General Scler Frontotemporal Degener Albert Ludolph Olivier Hermine Scientific Committee

AIM ImmunoTech Inc.: AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)

Company's SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech
United States Thomask Equels William Mitchell Christopher Nicodemus Ronald Brus W Neal Burnette

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science